Klaviyo (NYSE: KVYO) CFO logs share conversions, sales and RSU tax moves
Rhea-AI Filing Summary
Klaviyo, Inc.’s Chief Financial Officer Amanda Whalen reported a mix of share conversions, sales, and tax-related dispositions in company stock. On February 13, she converted 14,000 Series B Common shares into Series A Common and sold 9,281 Series A shares at a weighted average price of $19.01, plus 4,719 shares at a weighted average of $18.63, with actual sale prices ranging from $18.52 to $19.75 per share.
On February 15, she converted an additional 29,513 Series B shares into Series A in connection with tax withholding on vested RSUs and had 45,307 Series A shares withheld to cover tax obligations. After these transactions, she held 426,425 shares of Series A Common Stock and 301,405 shares of Series B Common Stock, along with unvested RSUs, all under pre-arranged Rule 10b5-1 trading and equity plans.
Positive
- None.
Negative
- None.
Insights
CFO activity combines planned stock sales with routine RSU tax handling.
The transactions show Klaviyo CFO Amanda Whalen converting Series B Common into Series A Common and then selling a portion of Series A shares under a Rule 10b5-1 plan. Additional shares were withheld to satisfy tax obligations tied to RSU vesting, a common equity-compensation mechanism.
The weighted-average sale prices between $18.52 and $19.75 provide a narrow trading range but no direct signal on company fundamentals. Afterward, she still holds substantial Series A and Series B positions plus unvested RSUs, suggesting continued equity exposure. Overall, these look like administrative and liquidity-management moves rather than a thesis-changing event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Conversion | Series B Common Stock | 29,513 | $0.00 | -- |
| Conversion | Series A Common Stock | 29,513 | $0.00 | -- |
| Tax Withholding | Series A Common Stock | 45,307 | $18.60 | $843K |
| Conversion | Series B Common Stock | 14,000 | $0.00 | -- |
| Conversion | Series A Common Stock | 14,000 | $0.00 | -- |
| Sale | Series A Common Stock | 9,281 | $19.01 | $176K |
| Sale | Series A Common Stock | 4,719 | $18.63 | $88K |
Footnotes (1)
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2025. Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into one share of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.76 to $19.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.52 to $18.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents 29,513 shares of Series B Common Stock automatically converted into shares of Series A Common Stock in connection with tax withholding obligations related to the vesting and settlement of restricted stock units ("RSUs"). Represents shares of Series A Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs. Consists of (i) 66,394 shares of Series A Common Stock and (ii) 360,031 unvested RSUs awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement. Consists of (i) 267,030 shares of Series B Common Stock and (ii) 34,375 unvested RSUs awarded under the Issuer's 2015 Stock Incentive Plan, each representing the contingent right to receive one share of Series B Common Stock upon vesting and settlement.
